|
Volumn 26, Issue 8, 2006, Pages 1170-1172
|
Clinical pharmacokinetic study of cisplatin in enhancing cervical cancer radiosensitivity
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
RADIOSENSITIZING AGENT;
ADULT;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
RADIATION DOSE;
RANDOMIZED CONTROLLED TRIAL;
SQUAMOUS CELL CARCINOMA;
TIME;
TREATMENT OUTCOME;
UTERINE CERVIX TUMOR;
ADULT;
ANTINEOPLASTIC AGENTS;
CARCINOMA, SQUAMOUS CELL;
CISPLATIN;
COMBINED MODALITY THERAPY;
FEMALE;
HUMANS;
INFUSIONS, INTRAVENOUS;
MIDDLE AGED;
RADIATION DOSAGE;
RADIATION-SENSITIZING AGENTS;
TIME FACTORS;
TREATMENT OUTCOME;
UTERINE CERVICAL NEOPLASMS;
|
EID: 42949127219
PISSN: 16734254
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|